Henry W. B. Johnson

Required Immunoproteasome Subunit Inhibition Profile for Anti-Inflammatory Efficacy and Clinical Candidate KZR-616 ((2<i>S</i>,3<i>R</i>)-<i>N</i>-((<i>S</i>)-3-(Cyclopent-1-en-1-yl)-1-((<i>R</i>)-2-methyloxiran-2-yl)-1-oxopropan-2-yl)-3-hydroxy-3-(4-methoxyphenyl)-2-((<i>S</i>)-2-(2-morpholinoacetamido)propanamido)propenamide)

Henry W. B. Johnson, Eric Lowe, Janet L. Anderl et al. · Journal of Medicinal Chemistry · 2018 · 97 citations · Full text

Immunology, Dual Lmp7/lmp2, Pharmacotherapy +20

The Total Synthesis of Gambierol

Henry W. B. Johnson, Utpal Majumder, Jon D. Rainier · Journal of the American Chemical Society · 2004 · 96 citations

C-Glycosides to fused polycyclic ethers

Shawn P. Allwein, Jason M. Cox, Brett E. Howard et al. · Tetrahedron · 2002 · 96 citations

Heterocyclic, Polycyclic Ethers, Organic Chemistry +3

Total Synthesis of Gambierol: The Generation of the A–C and F–H Subunits by Using a C‐Glycoside Centered Strategy

Utpal Majumder, Jason M. Cox, Henry W. B. Johnson et al. · Chemistry - A European Journal · 2005 · 92 citations

Discovery of a Novel Class of Highly Potent, Selective, ATP-Competitive, and Orally Bioavailable Inhibitors of the Mammalian Target of Rapamycin (mTOR)

Craig S. Takeuchi, Byung Gyu Kim, Charles M. Blazey et al. · Journal of Medicinal Chemistry · 2013 · 65 citations · Full text

Compound 28, Drug Target, Pharmacotherapy +20